GGrantIndex
← Leaderboards

John Daniel Clarke

Washington State University

$3,673,284
Attributed
$3,673,284
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $685.3K · FY201525
$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,673,284 · 5

By mechanism

R01$2,132,242 · 1
R00$714,616 · 1
R21$420,750 · 1
R56$222,910 · 1
K99$182,766 · 1

Top collaborators

No co-investigators on record.

Most similar at Washington State University

Same institution · by research overlap

Others in their field

Top investigators on “Hepatocyte

Research focus

HepatocyteIn VitroIn VivoUptakePathway InteractionsLiver DiseasesMediatingExposure ToCellsNonalcoholic SteatohepatitisNational Institute Of Environmental Health SciencesAnimalsLiverToxinCyanoginosin LrRattusCyanobacteriumDietScientistBaseNon-Alcoholic Fatty Liver DiseasePositioning AttributeHepaticPharmaceutical Preparations

Grant awards (13)

Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis$379,765
R01 · FY2025 · ES · contact PI
Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis$384,492
R01 · FY2024 · ES · contact PI
Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis$420,750
R01 · FY2023 · ES · contact PI
Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis$491,425
R01 · FY2022 · ES · contact PI
Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis$455,810
R01 · FY2021 · ES · contact PI
Enteric and hepatic transporter mechanisms for pharmacokinetic natural product-drug interactions$229,500
R21 · FY2021 · AT · contact PI
Risk of xenobiotic-drug interactions in chronic disease$222,910
R56 · FY2020 · AT · contact PI
Enteric and hepatic transporter mechanisms for pharmacokinetic natural product-drug interactions$191,250
R21 · FY2020 · AT · contact PI
Microcystin-LR toxicity in nonalcoholic steatohepatitis$237,186
R00 · FY2019 · ES · contact PI
Microcystin-LR toxicity in nonalcoholic steatohepatitis$228,430
R00 · FY2018 · ES · contact PI
Microcystin-LR toxicity in nonalcoholic steatohepatitis$249,000
R00 · FY2017 · ES · contact PI
Microcystin-LR toxicity in nonalcoholic steatohepatitis$91,383
K99 · FY2016 · ES · contact PI
Microcystin-LR toxicity in nonalcoholic steatohepatitis$91,383
K99 · FY2015 · ES · contact PI